1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. Src
  4. Fgr Isoform

Fgr

Fgr is a Src family tyrosine kinase activated during β2 integrin-dependent signaling in human neutrophils, linking adhesion to protein tyrosine phosphorylation[1]. Mechanistically, Fgr and Hck support adhesion-dependent neutrophil respiratory burst, spreading, and degranulation, showing that Fgr participates in integrin-driven inflammatory effector functions[2][3]. Fgr also acts with Hck to negatively regulate neutrophil and dendritic-cell chemokine signaling through PIR-B, indicating a context-dependent role in myeloid signal control[4]. In disease models, hematopoietic loss of Hck, Fgr, and Lyn protected mice from autoantibody-induced arthritis, blistering skin inflammation, and reverse passive Arthus reaction by impairing inflammatory-environment generation rather than intrinsic leukocyte recruitment[5]. Compared with related Src family isoforms, Fgr shows substantial functional overlap with Hck and Lyn, because single Fgr deficiency did not block arthritis development, whereas combined Hck/Fgr/Lyn loss produced complete protection[5]. For experimental applications, an Fgr kinase inhibitor attenuated sepsis-associated encephalopathy by reducing mitochondrial dysfunction, oxidative stress, and neuroinflammation through the SIRT1/PGC-1α pathway[6].

Fgr Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-178014
    SIK1-IN-1
    Inhibitor
    SIK1-IN-1 (Compound 27) is a selective Salt-inducible kinase 1 (SIK1) inhibitor with an IC50 of 0.7  nM for SIK1 over SIK2 and SIK3. SIK1-IN-1 has no cytotoxicity against HEK293 cells and PBMCs (maximum concentration of 30 μM). SIK1-IN-1 also has potent inhibitory activities for 392 kinases, in particular tyrosine kinases, such as FGR, HCK and LYN).